Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Int J Mol Sci ; 22(6)2021 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-33809345

RESUMEN

Physiological oxygen tension rises dramatically in the placenta between 8 and 14 weeks of gestation. Abnormalities in this period can lead to gestational diseases, whose underlying mechanisms remain unclear. We explored the changes at mRNA level by comparing the transcriptomes of human placentas at 8-10 gestational weeks and 12-14 gestational weeks. A total of 20 samples were collected and divided equally into four groups based on sex and age. Cytotrophoblasts were isolated and sequenced using RNAseq. Key genes were identified using two different methods: DESeq2 and weighted gene co-expression network analysis (WGCNA). We also constructed a local database of known targets of hypoxia-inducible factor (HIF) subunits, alpha and beta, to investigate expression patterns likely linked with changes in oxygen. Patterns of gene enrichment in and among the four groups were analyzed based on annotations of gene ontology (GO) and KEGG pathways. We characterized the similarities and differences between the enrichment patterns revealed by the two methods and the two conditions (age and sex), as well as those associated with HIF targets. Our results provide a broad perspective of the processes that are active in cytotrophoblasts during the rise in physiological oxygen, which should benefit efforts to discover possible drug-targeted genes or pathways in the human placenta.


Asunto(s)
Adaptación Fisiológica/genética , Preeclampsia/genética , Primer Trimestre del Embarazo/genética , Transcriptoma/genética , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico , Hipoxia de la Célula/genética , Femenino , Humanos , Oxígeno/metabolismo , Placenta/metabolismo , Placenta/patología , Placentación/genética , Preeclampsia/patología , Embarazo , Primer Trimestre del Embarazo/metabolismo , ARN Mensajero/genética , RNA-Seq
2.
FASEB J ; 32(6): 3108-3118, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29401599

RESUMEN

Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biologic functions, the contribution of endothelial TXNIP has not been well defined. To investigate the endothelial function of TXNIP, we generated a TXNIP knockout mouse on the Cdh5-cre background (TXNIPfl/fl cdh5cre). Control (TXNIPfl/fl) and TXNIPfl/fl cdh5cre mice were fed a high protein-low carbohydrate (HP-LC) diet for 3 mo to induce metabolic stress. We found that TXNIPfl/fl and TXNIPfl/fl cdh5cre mice on an HP-LC diet displayed impaired glucose tolerance and dyslipidemia concretizing the metabolic stress induced. We evaluated the impact of this metabolic stress on mice with reduced endothelial TXNIP expression with regard to arterial structure and function. TXNIPfl/fl cdh5cre mice on an HP-LC diet exhibited less endothelial dysfunction than littermate mice on an HP-LC diet. These mice were protected from decreased aortic medial cell content, impaired aortic distensibility, and increased plasminogen activator inhibitor 1 secretion. This protective effect came with lower oxidative stress and lower inflammation, with a reduced NLRP3 inflammasome expression, leading to a decrease in cleaved IL-1ß. We also show the major role of TXNIP in inflammation with a knockdown model, using a TXNIP-specific, small interfering RNA included in a lipoplex. These findings demonstrate a key role for endothelial TXNIP in arterial impairments induced by metabolic stress, making endothelial TXNIP a potential therapeutic target.-Bedarida, T., Domingues, A., Baron, S., Ferreira, C., Vibert, F., Cottart, C.-H., Paul, J.-L., Escriou, V., Bigey, P., Gaussem, P., Leguillier, T., Nivet-Antoine, V. Reduced endothelial thioredoxin-interacting protein protects arteries from damage induced by metabolic stress in vivo.


Asunto(s)
Aorta/metabolismo , Proteínas Portadoras/metabolismo , Dislipidemias/metabolismo , Intolerancia a la Glucosa/metabolismo , Estrés Fisiológico , Tiorredoxinas/metabolismo , Animales , Aorta/patología , Proteínas Portadoras/genética , Dieta Baja en Carbohidratos/efectos adversos , Proteínas en la Dieta/efectos adversos , Proteínas en la Dieta/farmacología , Dislipidemias/inducido químicamente , Dislipidemias/genética , Dislipidemias/patología , Intolerancia a la Glucosa/inducido químicamente , Intolerancia a la Glucosa/genética , Intolerancia a la Glucosa/patología , Inflamasomas/genética , Inflamasomas/metabolismo , Ratones , Ratones Noqueados , Proteína con Dominio Pirina 3 de la Familia NLR/biosíntesis , Serpina E2/biosíntesis , Tiorredoxinas/genética
3.
Int J Mol Sci ; 19(12)2018 Nov 27.
Artículo en Inglés | MEDLINE | ID: mdl-30486367

RESUMEN

The human placenta is an organ between the blood of the mother and the fetus, which is essential for fetal development. It also plays a role as a selective barrier against environmental pollutants that may bypass epithelial barriers and reach the placenta, with implications for the outcome of pregnancy. The aryl hydrocarbon receptor (AhR) is one of the most important environmental-sensor transcription factors and mediates the metabolism of a wide variety of xenobiotics. Nevertheless, the identification of dietary and endogenous ligands of AhR suggest that it may also fulfil physiological functions with which pollutants may interfere. Placental AhR expression and activity is largely unknown. We established the cartography of AhR expression at transcript and protein levels, its cellular distribution, and its transcriptional activity toward the expression of its main target genes. We studied the profile of AhR expression and activity during different pregnancy periods, during trophoblasts differentiation in vitro, and in a trophoblast cell line. Using diverse methods, such as cell fractionation and immunofluorescence microscopy, we found a constitutive nuclear localization of AhR in every placental model, in the absence of any voluntarily-added exogenous activator. Our data suggest an intrinsic activation of AhR due to the presence of endogenous placental ligands.


Asunto(s)
Expresión Génica , Placenta/metabolismo , Receptores de Hidrocarburo de Aril/genética , Receptores de Hidrocarburo de Aril/metabolismo , Animales , Biomarcadores , Vellosidades Coriónicas/metabolismo , Femenino , Regulación de la Expresión Génica , Humanos , Estrés Oxidativo , Embarazo , Unión Proteica , Transporte de Proteínas , Trofoblastos/metabolismo
4.
Am J Physiol Heart Circ Physiol ; 307(5): H649-57, 2014 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-25015969

RESUMEN

High-protein-low-carbohydrate (HP-LC) diets have become widespread. Yet their deleterious consequences, especially on glucose metabolism and arteries, have already been underlined. Our previous study (2) has already shown glucose intolerance with major arterial dysfunction in very old mice subjected to an HP-LC diet. The hypothesis of this work was that this diet had an age-dependent deleterious metabolic and cardiovascular outcome. Two groups of mice, young and adult (3 and 6 mo old), were subjected for 12 wk to a standard or to an HP-LC diet. Glucose and lipid metabolism was studied. The cardiovascular system was explored from the functional stage with Doppler-echography to the molecular stage (arterial reactivity, mRNA, immunohistochemistry). Young mice did not exhibit any significant metabolic modification, whereas adult mice presented marked glucose intolerance associated with an increase in resistin and triglyceride levels. These metabolic disturbances were responsible for cardiovascular damages only in adult mice, with decreased aortic distensibility and left ventricle dysfunction. These seemed to be the consequence of arterial dysfunctions. Mesenteric arteries were the worst affected with a major oxidative stress, whereas aorta function seemed to be maintained with an appreciable role of cyclooxygenase-2 to preserve endothelial function. This study highlights for the first time the age-dependent deleterious effects of an HP-LC diet on metabolism, with glucose intolerance and lipid disorders and vascular (especially microvessels) and cardiac functions. This work shows that HP-LC lead to equivalent cardiovascular alterations, as observed in very old age, and underlines the danger of such diet.


Asunto(s)
Aorta/metabolismo , Dieta Baja en Carbohidratos/efectos adversos , Proteínas en la Dieta/administración & dosificación , Intolerancia a la Glucosa/etiología , Miocardio/metabolismo , Disfunción Ventricular Izquierda/etiología , Factores de Edad , Animales , Aorta/patología , Glucemia/metabolismo , Proteínas en la Dieta/efectos adversos , Ecocardiografía , Intolerancia a la Glucosa/metabolismo , Metabolismo de los Lípidos , Arterias Mesentéricas/metabolismo , Arterias Mesentéricas/patología , Ratones , Ratones Endogámicos C57BL , Miocardio/patología , Resistina/sangre , Triglicéridos/sangre , Disfunción Ventricular Izquierda/metabolismo
5.
Placenta ; 100: 81-88, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32871493

RESUMEN

INTRODUCTION: Pregnant women with sickle cell disease (SCD) are at high risk for sickle cell-related complications, obstetrical complications, and perinatal morbidity. Chronic inflammation and the proangiogenic environment associated with SCD have been associated with endothelial damage. It is unknown whether SCD complications could be associated with placental dysfunction or abnormal placental morphology. Moreover, circulating angiogenic factors in pregnant women with SCD are unexplored. METHODS: Clinical records, placental and blood samples were collected at term delivery for 21 pregnant patients with SCD and 19 HbAA pregnant controls with adapted to gestational age birth weight newborns. Histological and stereological analyses and scanning electron microscopy (SEM) of the placenta, and PlGF and sFlt1 measurements in blood were performed. RESULTS: In the SCD group, the parenchyma-forming villi of placentas were thinner than in controls, and increased fibrinoid necrosis and an overabundance of syncytial knots were seen. SEM revealed elongated intermediate villous endings with a reduction in the number of terminal villi compared to controls, indicating a significant branching defect in SCD placentas. Finally, SCD patients had an imbalance in the angiogenic ratio of sFlt1/PlGF (p = 0.008) with a drop of PlGF concentrations. DISCUSSION: We evidence for the first time both abnormal placenta morphology and altered sFlt1/PlGF ratio in SCD patients, uncorrelated with maintained placental efficiency and fetal growth.


Asunto(s)
Anemia de Células Falciformes/patología , Placenta/ultraestructura , Adulto , Anemia de Células Falciformes/sangre , Anemia de Células Falciformes/fisiopatología , Estudios de Casos y Controles , Femenino , Humanos , Placenta/fisiopatología , Factor de Crecimiento Placentario/sangre , Embarazo , Estudios Prospectivos , Receptor 1 de Factores de Crecimiento Endotelial Vascular/sangre
6.
Nanomaterials (Basel) ; 10(7)2020 Jul 03.
Artículo en Inglés | MEDLINE | ID: mdl-32635405

RESUMEN

The human placenta is at the interface between maternal and fetal circulations, and is crucial for fetal development. The nanoparticles of cerium dioxide (CeO2 NPs) from air pollution are an unevaluated risk during pregnancy. Assessing the consequences of placenta exposure to CeO2 NPs could contribute to a better understanding of NPs' effect on the development and functions of the placenta and pregnancy outcome. We used primary villous cytotrophoblasts purified from term human placenta, with a wide range of CeO2 NPs concentrations (0.1-101 µg/cm2) and exposure time (24-72 h), to assess trophoblast uptake, toxicity and impact on trophoblast differentiation and endocrine function. We have shown the capacity of both cytotrophoblasts and syncytiotrophoblasts to internalize CeO2 NPs. CeO2 NPs affected trophoblast metabolic activity in a dose and time dependency, induced caspase activation and a LDH release in the absence of oxidative stress. CeO2 NPs decreased the fusion capacity of cytotrophoblasts to form a syncytiotrophoblast and disturbed secretion of the pregnancy hormones hCG, hPL, PlGF, P4 and E2, in accordance with NPs concentration. This is the first study on the impact of CeO2 NPs using human primary trophoblasts that decrypts their toxicity and impact on placental formation and functions.

7.
Liver Transpl ; 14(4): 451-9, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18383089

RESUMEN

Liver ischemia-reperfusion (I/R) injury occurs in many clinical conditions, including liver surgery and transplantation. Oxygen free radicals generated during I/R reduce endogenous antioxidant systems and contribute to hepatic injury. trans-Resveratrol (trans-3,5,4'-trihydroxystilbene) is reported to have antioxidant properties. We investigated the effect of trans-resveratrol on liver injury induced by I/R. After 1 hour of ischemia, administered 5 minutes before 3 hours of reperfusion, trans-resveratrol was hepatoprotective at a low dose (0.02 mg/kg). It significantly decreased aminotransferase levels by about 40% and improved sinusoidal dilatation. trans-Resveratrol preserved antioxidant defense by preventing total and reduced glutathione depletion caused by I/R. At 0.2 mg/kg, trans-resveratrol significantly increased glutathione reductase, Cu/Zn-superoxide dismutase, and catalase activities. However, at a high dose (20 mg/kg), trans-resveratrol became prooxidant with an aggravation of liver injury evaluated by aminotransferase release and histological analysis and associated with a depletion of total and reduced glutathione levels and a decrease of antioxidant enzyme activities. In conclusion, a prereperfusion treatment by trans-resveratrol only at low doses decreases liver injury induced by I/R by protecting against antioxidant defense failure. This administration protocol could reduce liver damage during surgery or transplantation.


Asunto(s)
Daño por Reperfusión/prevención & control , Estilbenos/uso terapéutico , Animales , Antineoplásicos Fitogénicos/uso terapéutico , Catalasa/metabolismo , Glucosafosfato Deshidrogenasa/metabolismo , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/metabolismo , Arteria Hepática , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/metabolismo , Circulación Hepática/efectos de los fármacos , Masculino , Ratas , Ratas Sprague-Dawley , Daño por Reperfusión/tratamiento farmacológico , Resveratrol , Superóxido Dismutasa/metabolismo , Vasodilatadores/uso terapéutico
8.
J Gerontol A Biol Sci Med Sci ; 71(6): 720-9, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-26041427

RESUMEN

Aging leads to a high prevalence of glucose intolerance and cardiovascular diseases, with oxidative stress playing a potential role. Resveratrol has shown promising effects on glucose tolerance and tends to improve endothelial function in elderly patients. Thioredoxin-interacting protein (TXNIP) was recently proposed as a potential link connecting glucose metabolism to oxidative stress. Here, we investigated the resveratrol-induced improvement of arterial aging phenotype in old mice and the expression of aortic TXNIP. Using an in vivo model of old mice with or without 3-month resveratrol treatment, we investigated the effects of resveratrol on age-related impairments from a cardiovascular Doppler analysis, to a molecular level, by studying inflammation and oxidative stress factors. We found a dual effect of resveratrol, with a decrease of age-related glucose intolerance and oxidative stress imbalance leading to reduced matrix remodeling that forestalls arterial aging phenotype in terms of intima-media thickness and arterial distensibility. These results provide the first evidence that aortic TXNIP mRNA and protein nuclear expressions are increased in the arterial aging and decreased by resveratrol treatment. In conclusion, we demonstrated that resveratrol helped to restore several aging impaired processes in old mice, with a decrease of aortic TXNIP mRNA and protein nuclear expressions.


Asunto(s)
Aorta/diagnóstico por imagen , Aorta/metabolismo , Proteínas Portadoras/metabolismo , Intolerancia a la Glucosa/tratamiento farmacológico , Proteínas Nucleares/metabolismo , ARN Mensajero/metabolismo , Estilbenos/farmacología , Tiorredoxinas/metabolismo , Animales , Calcio/sangre , Ecocardiografía Doppler , Prueba de Tolerancia a la Glucosa , Inmunohistoquímica , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Estrés Oxidativo/efectos de los fármacos , Fenotipo , Distribución Aleatoria , Reacción en Cadena en Tiempo Real de la Polimerasa , Resveratrol
9.
J Gerontol A Biol Sci Med Sci ; 69(3): 260-9, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23793060

RESUMEN

Aging leads to increased insulin resistance and arterial dysfunction, with oxidative stress playing an important role. This study explored the metabolic and arterial effects of a chronic treatment with resveratrol, an antioxidant polyphenol compound that has been shown to restore insulin sensitivity and decrease oxidative stress, in old mice with or without a high-protein diet renutrition care. High-protein diet tended to increase insulin resistance and atheromatous risk. Resveratrol improved insulin sensitivity in old mice fed standard diet by decreasing homeostasis model of assessment-insulin resistance and resistin levels. However, resveratrol did not improve insulin resistance status in old mice receiving the high-protein diet. In contrast, resveratrol exhibited deleterious effects by increasing inflammation state and superoxide production and diminishing aortic distensibility. In conclusion, we demonstrate that resveratrol has beneficial or deleterious effects on insulin sensitivity and arterial function, depending on nutritional status in our models.


Asunto(s)
Envejecimiento/efectos de los fármacos , Antioxidantes/uso terapéutico , Aorta/efectos de los fármacos , Resistencia a la Insulina/fisiología , Fenoles/uso terapéutico , Ribonucleótido Reductasas/antagonistas & inhibidores , Estilbenos/uso terapéutico , Enfermedades Vasculares/tratamiento farmacológico , Animales , Glucemia/análisis , Quimiocina CCL5/sangre , Quimiocina CXCL1/sangre , Proteínas en la Dieta/administración & dosificación , Modelos Animales de Enfermedad , Leptina/sangre , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos , Estado Nutricional , Estrés Oxidativo/efectos de los fármacos , Resistina/análisis , Resveratrol , Albúmina Sérica/análisis , Superóxidos/metabolismo , Factor de Necrosis Tumoral alfa/análisis , Capacitancia Vascular/efectos de los fármacos , Vasodilatación/efectos de los fármacos
10.
Biochimie ; 92(4): 405-10, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20036306

RESUMEN

Oxidative and inflammatory processes are elicited during hepatic post-ischemic reperfusion and generate liver damage. This study investigated the early anti-inflammatory effect of trans-resveratrol (T-res) and its consequences on the late self-aggravating inflammatory process in liver ischemia-reperfusion (I/R). Partial hepatic ischemia was initiated in rats for 1 h and T-res (0.02 and 0.2 mg/kg) was administered intravenously 5 min before starting reperfusion for 3 h. Plasma levels of aminotransferases and cytokines (tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-6) and hepatic neutrophil recruitment were assessed. Hepatic expression of stress protein (heat-shock protein (HSP-70), heme oxygenase-1(HO-1)) and cytokine (TNF-alpha, IL-1beta, keratinocyte chemoattractant (KC)) mRNA was investigated. I/R caused an increase in aminotransferase levels and increased polymorphonuclear cell infiltration. Post-ischemic treatment with T-res (0.02 and 0.2 mg/kg) resulted in a significant decrease in aminotransferase, IL-1beta and IL-6 plasma levels by about 40%, 60% and 40%, respectively, compared to the vehicle I/R group. Post-ischemic treatment with T-res (0.02 mg/kg) also significantly decreased hepatic neutrophil recruitment. TNF-alpha, IL-1beta, KC and HO-1 hepatic mRNA expression was reduced by T-res without any change in HSP-70 mRNA. This T-res mediated decrease in early release of cytokines and neutrophil recruitment led to a reduction in the late inflammatory process. T-resveratrol might be useful in the prevention of inflammation secondary to hepatic surgery or liver transplantation.


Asunto(s)
Hígado/inmunología , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/fisiopatología , Estilbenos/uso terapéutico , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/sangre , Quimiocinas CXC/sangre , Hemo-Oxigenasa 1/sangre , Interleucina-1beta/sangre , Interleucina-6/sangre , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Infiltración Neutrófila , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Resveratrol , Estilbenos/administración & dosificación , Factor de Necrosis Tumoral alfa/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA